H2 Equity Partners (“H2”) is pleased to announce that it has invested in NRS Healthcare (“NRS” or the “Company”).
H2 partially bought out existing shareholder LDC, a mid-market private equity investor, and has become the majority shareholder in the Company. LDC will retain a minority investment in the Company, alongside the incumbent management team.
NRS Healthcare is a market leading outsourced provider of specialist community healthcare equipment and services to the NHS and local authorities. The firm’s products and services enable people with mobility issues to be self-sufficient within the home either to delay or prevent more expensive residential or acute care. Based in Leicestershire, NRS employs 734 employees across the UK and is forecast to generate sales of £132 million in current financial year.
H2 intends to build on NRS’s market leadership of a sector that has been growing strongly due to outsourcing of care services and the demands of an ageing population. H2 will support the Company’s growth by working with the management team to develop the lead provider model and retail proposition.
Commenting on the transaction, Phil Isherwood, CEO at NRS Healthcare, said:
“We are excited to bring H2 on board as investors and are looking forward to the next phase of the Company’s growth, where we will focus on developing our proposition and the range of products and services we can offer our customers”.
